{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:00:22Z","timestamp":1789214422006,"version":"build-2803163510"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurodegenerative disorders, including Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS), are characterized by the progressive and gradual degeneration of neurons. The prevalence and rates of these disorders rise significantly with age. As life spans continue to increase in many countries, the number of cases is expected to grow in the foreseeable future. Early and precise diagnosis, along with appropriate surveillance, continues to pose a challenge. The high heterogeneity of neurodegenerative diseases calls for more accurate and definitive biomarkers to improve clinical therapy. Cell-free DNA (cfDNA), including fragmented DNA released into bodily fluids via apoptosis, necrosis, or active secretion, has emerged as a promising non-invasive diagnostic tool for various disorders including neurodegenerative diseases. cfDNA can serve as an indicator of ongoing cellular damage and mortality, including neuronal loss, and may provide valuable insights into disease processes, progression, and therapeutic responses. This review will first cover the key aspects of cfDNA and then examine recent advances in its potential use as a biomarker for neurodegenerative disorders.<\/jats:p>","DOI":"10.1007\/s12031-025-02317-8","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:08:53Z","timestamp":1741835333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5640-3363","authenticated-orcid":false,"given":"\u015eeyma","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-0523","authenticated-orcid":false,"given":"Sel\u00e7uk","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-6647","authenticated-orcid":false,"given":"Ahmet","family":"Ad\u0131g\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"2317_CR1","doi-asserted-by":"publisher","first-page":"43035","DOI":"10.1007\/s11042-023-17326-1","volume":"83","author":"B Abhisheka","year":"2024","unstructured":"Abhisheka B, Biswas SK, Purkayastha B et al (2024) Recent trend in medical imaging modalities and their applications in disease diagnosis: a review. Multimed Tools Appl 83:43035\u201343070. https:\/\/doi.org\/10.1007\/s11042-023-17326-1","journal-title":"Multimed Tools Appl"},{"key":"2317_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease. JAMA 323:548. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"2317_CR3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/kjm2.12870","volume":"40","author":"AD Assfaw","year":"2024","unstructured":"Assfaw AD, Schindler SE, Morris JC (2024) Advances in blood biomarkers for Alzheimer disease (AD): a review. Kaohsiung J Med Sci 40:692\u2013698","journal-title":"Kaohsiung J Med Sci"},{"key":"2317_CR4","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/cells11111744","volume":"11","author":"RO Bahado-Singh","year":"2022","unstructured":"Bahado-Singh RO, Radhakrishna U, Gordevi\u010dius J et al (2022) Artificial intelligence and circulating cell-free DNA methylation profiling: mechanism and detection of Alzheimer\u2019s disease. Cells 11:1744. https:\/\/doi.org\/10.3390\/cells11111744","journal-title":"Cells"},{"key":"2317_CR5","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3390\/ijms24032876","volume":"24","author":"RO Bahado-Singh","year":"2023","unstructured":"Bahado-Singh RO, Vishweswaraiah S, Turkoglu O et al (2023) Alzheimer\u2019s precision neurology: epigenetics of cytochrome P450 genes in circulating cell-free DNA for disease prediction and mechanism. Int J Mol Sci 24:2876. https:\/\/doi.org\/10.3390\/ijms24032876","journal-title":"Int J Mol Sci"},{"key":"2317_CR6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ccell.2017.01.002","volume":"31","author":"A Bardelli","year":"2017","unstructured":"Bardelli A, Pantel K (2017) Liquid biopsies, what we do not know (yet). Cancer Cell 31:172\u2013179","journal-title":"Cancer Cell"},{"key":"2317_CR7","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.3390\/ijms22126417","volume":"22","author":"E Bazzan","year":"2021","unstructured":"Bazzan E, Tin\u00e8 M, Casara A et al (2021) Critical review of the evolution of extracellular vesicles\u2019 knowledge: from 1946 to today. Int J Mol Sci 22:6417. https:\/\/doi.org\/10.3390\/ijms22126417","journal-title":"Int J Mol Sci"},{"key":"2317_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","volume":"379","author":"DW Bianchi","year":"2018","unstructured":"Bianchi DW, Chiu RWK (2018) Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med 379:464\u2013473. https:\/\/doi.org\/10.1056\/NEJMra1705345","journal-title":"N Engl J Med"},{"key":"2317_CR9","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/cancers14194882","volume":"14","author":"N Birknerova","year":"2022","unstructured":"Birknerova N, Mancikova V, Paul ED et al (2022) Circulating cell-free DNA-based methylation pattern in saliva for early diagnosis of head and neck cancer. Cancers (Basel) 14:4882. https:\/\/doi.org\/10.3390\/cancers14194882","journal-title":"Cancers (Basel)"},{"key":"2317_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/ph14060596","volume":"14","author":"E Bohers","year":"2021","unstructured":"Bohers E, Viailly PJ, Jardin F (2021) cfDNA sequencing: technological approaches and bioinformatic issues. Pharmaceuticals 14:596. https:\/\/doi.org\/10.3390\/ph14060596","journal-title":"Pharmaceuticals"},{"key":"2317_CR11","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/brain\/awaa246","volume":"143","author":"M Borsche","year":"2020","unstructured":"Borsche M, K\u00f6nig IR, Delcambre S et al (2020) Mitochondrial damage-associated inflammation highlights biomarkers in PRKN\/PINK1 parkinsonism. Brain 143:3041\u20133051. https:\/\/doi.org\/10.1093\/brain\/awaa246","journal-title":"Brain"},{"key":"2317_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00414-018-1945-y","volume":"133","author":"K Brodbeck","year":"2019","unstructured":"Brodbeck K, Kern S, Schick S et al (2019) Quantitative analysis of individual cell-free DNA concentration before and after penetrating trauma. Int J Legal Med 133:385\u2013393. https:\/\/doi.org\/10.1007\/s00414-018-1945-y","journal-title":"Int J Legal Med"},{"key":"2317_CR13","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/diagnostics12092147","volume":"12","author":"AJ Bronkhorst","year":"2022","unstructured":"Bronkhorst AJ, Ungerer V, Oberhofer A et al (2022) New perspectives on the importance of cell-free DNA biology. Diagnostics 12:2147. https:\/\/doi.org\/10.3390\/diagnostics12092147","journal-title":"Diagnostics"},{"key":"2317_CR14","doi-asserted-by":"publisher","unstructured":"Caggiano C, Morselli M, Qian X, Celona B, Thompson M, Wani S, Tosevska A, Taraszka K, Heuer G, Ngo S, Steyn F, Nestor P, Wallace L, McCombe P, Heggie S, Thorpe K, McElligott C, English G, Henders A, Henderson R, Lomen-Hoerth C, Wray N, McRae A, Pellegrini M, Garton F, Zaitlen N. (2024).Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis. medRxiv. https:\/\/doi.org\/10.1101\/2024.04.08.24305503","DOI":"10.1101\/2024.04.08.24305503"},{"key":"2317_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med 243:213\u2013221. https:\/\/doi.org\/10.1177\/1535370217750088","journal-title":"Exp Biol Med"},{"key":"2317_CR16","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2017.12","volume":"20","author":"P Celec","year":"2018","unstructured":"Celec P, Vlkov\u00e1 B, Laukov\u00e1 L et al (2018) Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases. Expert Rev Mol Med 20:e1. https:\/\/doi.org\/10.1017\/erm.2017.12","journal-title":"Expert Rev Mol Med"},{"key":"2317_CR17","doi-asserted-by":"publisher","unstructured":"Chai R, An S, Lin H, et al (2024) Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors. NPJ Precis Oncol 8. https:\/\/doi.org\/10.1038\/s41698-024-00541-w","DOI":"10.1038\/s41698-024-00541-w"},{"key":"2317_CR18","doi-asserted-by":"publisher","unstructured":"Charoensappakit A, Sae-khow K, Rattanaliam P, et al (2023) Cell-free DNA as diagnostic and prognostic biomarkers for adult sepsis: a systematic review and meta-analysis. Sci Rep 13. https:\/\/doi.org\/10.1038\/s41598-023-46663-2","DOI":"10.1038\/s41598-023-46663-2"},{"key":"2317_CR19","doi-asserted-by":"publisher","first-page":"S1645","DOI":"10.21037\/jtd.2018.04.68","volume":"10","author":"AH-K Cheung","year":"2018","unstructured":"Cheung AH-K, Chow C, To K-F (2018) Latest development of liquid biopsy. J Thorac Dis 10:S1645\u2013S1651. https:\/\/doi.org\/10.21037\/jtd.2018.04.68","journal-title":"J Thorac Dis"},{"key":"2317_CR20","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.3390\/ijms25147952","volume":"25","author":"E-H Choi","year":"2024","unstructured":"Choi E-H, Kim M-H, Park S-J (2024) Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment. Int J Mol Sci 25:7952. https:\/\/doi.org\/10.3390\/ijms25147952","journal-title":"Int J Mol Sci"},{"key":"2317_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/nejmoa2304714","volume":"390","author":"DC Chung","year":"2024","unstructured":"Chung DC, Gray DM, Singh H et al (2024) A cell-free DNA blood-based test for colorectal cancer screening. N Engl J Med 390:973\u2013983. https:\/\/doi.org\/10.1056\/nejmoa2304714","journal-title":"N Engl J Med"},{"issue":"3","key":"2317_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41416-021-01696-0","volume":"126","author":"M Cisneros-Villanueva","year":"2022","unstructured":"Cisneros-Villanueva M, Hidalgo-P\u00e9rez L, Rios-Romero M et al (2022) Cell-free DNA analysis in current cancer clinical trials: a review. Br J Cancer 126(3):391\u2013400","journal-title":"Br J Cancer"},{"key":"2317_CR23","doi-asserted-by":"publisher","first-page":"e0282332","DOI":"10.1371\/journal.pone.0282332","volume":"18","author":"FB Clausen","year":"2023","unstructured":"Clausen FB, J\u00f8rgensen KMCL, Wardil LW et al (2023) Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: methodological aspects. PLoS ONE 18:e0282332. https:\/\/doi.org\/10.1371\/journal.pone.0282332","journal-title":"PLoS ONE"},{"key":"2317_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/17501911.2024.2394380","volume":"16","author":"F Copped\u00e8","year":"2024","unstructured":"Copped\u00e8 F (2024) DNA methylation in amyotrophic lateral sclerosis: where do we stand and what is next? Epigenomics 16:1185\u20131196. https:\/\/doi.org\/10.1080\/17501911.2024.2394380","journal-title":"Epigenomics"},{"key":"2317_CR25","doi-asserted-by":"publisher","unstructured":"Cornelli L, Van Paemel R, Ferro dos Santos MR, et al (2024) Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid. Clin Epigenetics 16. https:\/\/doi.org\/10.1186\/s13148-024-01696-w","DOI":"10.1186\/s13148-024-01696-w"},{"key":"2317_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","volume":"10","author":"E Crowley","year":"2013","unstructured":"Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A (2013) Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 10:472\u2013484. https:\/\/doi.org\/10.1038\/nrclinonc.2013.110","journal-title":"Nat Rev Clin Oncol"},{"key":"2317_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1176\/appi.neuropsych.20060152","volume":"33","author":"J Cummings","year":"2021","unstructured":"Cummings J (2021) Drug development for psychotropic, cognitive-enhancing, and disease-modifying treatments for Alzheimer\u2019s disease. J Neuropsychiatry Clin Neurosci 33:3\u201313. https:\/\/doi.org\/10.1176\/appi.neuropsych.20060152","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2317_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cca.2021.05.033","volume":"520","author":"R Danesi","year":"2021","unstructured":"Danesi R, Lo YMD, Oellerich M et al (2021) What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? \u2013 considerations on pre-analytical aspects by the IFCC workgroup cfDNA. Clin Chim Acta 520:168\u2013171. https:\/\/doi.org\/10.1016\/j.cca.2021.05.033","journal-title":"Clin Chim Acta"},{"key":"2317_CR29","doi-asserted-by":"publisher","first-page":"13219","DOI":"10.3390\/ijms241713219","volume":"24","author":"J Dao","year":"2023","unstructured":"Dao J, Conway PJ, Subramani B et al (2023) Using cfDNA and ctDNA as oncologic markers: a path to clinical validation. Int J Mol Sci 24:13219. https:\/\/doi.org\/10.3390\/ijms241713219","journal-title":"Int J Mol Sci"},{"key":"2317_CR30","doi-asserted-by":"publisher","first-page":"115454","DOI":"10.1016\/j.ab.2023.115454","volume":"687","author":"D Das","year":"2024","unstructured":"Das D, Avssn R, Chittela RK (2024) A phenol-chloroform free method for cfDNA isolation from cell conditioned media: development, optimization and comparative analysis. Anal Biochem 687:115454. https:\/\/doi.org\/10.1016\/j.ab.2023.115454","journal-title":"Anal Biochem"},{"key":"2317_CR31","doi-asserted-by":"publisher","unstructured":"Di Sario G, Rossella V, Famulari ES, et al (2023) Enhancing clinical potential of liquid biopsy through a multi-omic approach: a systematic review. Front Genet 14. https:\/\/doi.org\/10.3389\/fgene.2023.1152470","DOI":"10.3389\/fgene.2023.1152470"},{"key":"2317_CR32","doi-asserted-by":"publisher","unstructured":"Dhama K, Latheef SK, Dadar M, et al (2019) Biomarkers in stress related diseases\/disorders: diagnostic, prognostic, and therapeutic values. Front Mol Biosci 6. https:\/\/doi.org\/10.3389\/fmolb.2019.00091","DOI":"10.3389\/fmolb.2019.00091"},{"key":"2317_CR33","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/diagnostics13071288","volume":"13","author":"IM Diaz","year":"2023","unstructured":"Diaz IM, Nocon A, Held SAE et al (2023) Pre-analytical evaluation of Streck Cell-Free DNA blood collection tubes for liquid profiling in oncology. Diagnostics 13:1288. https:\/\/doi.org\/10.3390\/diagnostics13071288","journal-title":"Diagnostics"},{"key":"2317_CR34","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/diagnostics12040978","volume":"12","author":"SC Ding","year":"2022","unstructured":"Ding SC, Lo YMD (2022) Cell-free DNA fragmentomics in liquid biopsy. Diagnostics 12:978. https:\/\/doi.org\/10.3390\/diagnostics12040978","journal-title":"Diagnostics"},{"key":"2317_CR35","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3390\/diagnostics13142351","volume":"13","author":"B Ding","year":"2023","unstructured":"Ding B, Zhang X, Wan Z et al (2023) Characterization of mitochondrial DNA methylation of Alzheimer\u2019s disease in plasma cell-free DNA. Diagnostics 13:2351. https:\/\/doi.org\/10.3390\/diagnostics13142351","journal-title":"Diagnostics"},{"key":"2317_CR36","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1007\/s12035-017-0679-z","volume":"55","author":"M Dunaeva","year":"2018","unstructured":"Dunaeva M, Derksen M, Pruijn GJM (2018) LINE-1 hypermethylation in serum cell-free DNA of relapsing remitting multiple sclerosis patients. Mol Neurobiol 55:4681\u20134688. https:\/\/doi.org\/10.1007\/s12035-017-0679-z","journal-title":"Mol Neurobiol"},{"key":"2317_CR37","doi-asserted-by":"publisher","unstructured":"Duvvuri B, Lood C (2019) Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.00502","DOI":"10.3389\/fimmu.2019.00502"},{"key":"2317_CR38","doi-asserted-by":"publisher","first-page":"111481","DOI":"10.1016\/j.ejrad.2024.111481","volume":"176","author":"R El Khalfi","year":"2024","unstructured":"El Khalfi R, Maupoint E, Chiavassa-Gandois H et al (2024) Assessment of whole-body muscle MRI for the early diagnosis of amyotrophic lateral sclerosis. Eur J Radiol 176:111481. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111481","journal-title":"Eur J Radiol"},{"key":"2317_CR39","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/1878-0261.12777","volume":"15","author":"J Elzanowska","year":"2021","unstructured":"Elzanowska J, Semira C, Costa-Silva B (2021) DNA in extracellular vesicles: biological and clinical aspects. Mol Oncol 15:1701\u20131714. https:\/\/doi.org\/10.1002\/1878-0261.12777","journal-title":"Mol Oncol"},{"key":"2317_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/uog.14746","volume":"45","author":"TR Everett","year":"2015","unstructured":"Everett TR, Chitty LS (2015) Cell-free fetal DNA: the new tool in fetal medicine. Ultrasound Obstet Gynecol 45:499\u2013507. https:\/\/doi.org\/10.1002\/uog.14746","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2317_CR41","volume-title":"BEST (Biomarkers, EndpointS, and other Tools) resource","author":"FDA-NIH BIOMARKER WORKING GROUP","year":"2016","unstructured":"FDA-NIH BIOMARKER WORKING GROUP (2016) BEST (Biomarkers, EndpointS, and other Tools) resource. Silver Spring, US FDA"},{"key":"2317_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/diagnostics10070443","volume":"10","author":"D Fern\u00e1ndez-L\u00e1zaro","year":"2020","unstructured":"Fern\u00e1ndez-L\u00e1zaro D, Garc\u00eda Hern\u00e1ndez JL, Caballero Garc\u00eda A et al (2020) Clinical perspective and translational oncology of liquid biopsy. Diagnostics 10:443. https:\/\/doi.org\/10.3390\/diagnostics10070443","journal-title":"Diagnostics"},{"key":"2317_CR43","doi-asserted-by":"publisher","first-page":"e0183915","DOI":"10.1371\/journal.pone.0183915","volume":"12","author":"MR Fernando","year":"2017","unstructured":"Fernando MR, Jiang C, Krzyzanowski GD, Ryan WL (2017) New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS ONE 12:e0183915. https:\/\/doi.org\/10.1371\/journal.pone.0183915","journal-title":"PLoS ONE"},{"key":"2317_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","volume":"29","author":"PV Fish","year":"2019","unstructured":"Fish PV, Steadman D, Bayle ED, Whiting P (2019) New approaches for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 29:125\u2013133. https:\/\/doi.org\/10.1016\/j.bmcl.2018.11.034","journal-title":"Bioorg Med Chem Lett"},{"key":"2317_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford H (2020) Clinical presentation and diagnosis of multiple sclerosis. Clin Med 20:380\u2013383. https:\/\/doi.org\/10.7861\/clinmed.2020-0292","journal-title":"Clin Med"},{"key":"2317_CR46","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/brain\/awac438","volume":"146","author":"H Gaitsch","year":"2023","unstructured":"Gaitsch H, Franklin RJM, Reich DS (2023) Cell-free DNA-based liquid biopsies in neurology. Brain 146:1758\u20131774. https:\/\/doi.org\/10.1093\/brain\/awac438","journal-title":"Brain"},{"key":"2317_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcdb.2014.02.006","volume":"35","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Kepp O, Krautwald S et al (2014) Molecular mechanisms of regulated necrosis. Semin Cell Dev Biol 35:24\u201332. https:\/\/doi.org\/10.1016\/j.semcdb.2014.02.006","journal-title":"Semin Cell Dev Biol"},{"key":"2317_CR48","doi-asserted-by":"publisher","unstructured":"Gambardella S, Limanaqi F, Ferese R, et al (2019) ccf-mtDNA as a potential link between the brain and immune system in neuro-immunological disorders. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.01064","DOI":"10.3389\/fimmu.2019.01064"},{"key":"2317_CR49","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jmoldx.2020.05.006","volume":"22","author":"T Gerber","year":"2020","unstructured":"Gerber T, Taschner-Mandl S, Saloberger-Sindh\u00f6ringer L et al (2020) Assessment of pre-analytical sample handling conditions for comprehensive liquid biopsy analysis. J Mol Diagn 22:1070\u20131086. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.05.006","journal-title":"J Mol Diagn"},{"key":"2317_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jss.jss_24_24","volume":"51","author":"SC Ghagane","year":"2024","unstructured":"Ghagane SC, Nerli RB (2024) Molecular biomarkers: current advances in liquid biopsy in the diagnosis of cancer. Journal of the Scientific Society 51:1\u20132. https:\/\/doi.org\/10.4103\/jss.jss_24_24","journal-title":"Journal of the Scientific Society"},{"key":"2317_CR51","doi-asserted-by":"publisher","first-page":"a024125","DOI":"10.1101\/cshperspect.a024125","volume":"8","author":"M Ghasemi","year":"2018","unstructured":"Ghasemi M, Brown RH (2018) Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect Med 8:a024125. https:\/\/doi.org\/10.1101\/cshperspect.a024125","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2317_CR52","doi-asserted-by":"publisher","first-page":"a026757","DOI":"10.1101\/cshperspect.a026757","volume":"8","author":"I Gijselinck","year":"2018","unstructured":"Gijselinck I, Cruts M, Van Broeckhoven C (2018) The genetics of C9orf72 expansions. Cold Spring Harb Perspect Med 8:a026757. https:\/\/doi.org\/10.1101\/cshperspect.a026757","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2317_CR53","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.cdd.4400851","volume":"8","author":"S Gobeil","year":"2001","unstructured":"Gobeil S, Boucher CC, Nadeau D, Poirier GG (2001) Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ 8:588\u2013594. https:\/\/doi.org\/10.1038\/sj.cdd.4400851","journal-title":"Cell Death Differ"},{"key":"2317_CR54","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/1078-0432.CCR-17-1341","volume":"24","author":"SB Goldberg","year":"2018","unstructured":"Goldberg SB, Narayan A, Kole AJ et al (2018) Early assessment of lung cancer immunotherapy response via circulating tumor DNA. Clin Cancer Res 24:1872\u20131880. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1341","journal-title":"Clin Cancer Res"},{"key":"2317_CR55","doi-asserted-by":"publisher","first-page":"119147","DOI":"10.1016\/j.bbamcr.2021.119147","volume":"1869","author":"Y Gong","year":"2022","unstructured":"Gong Y, Huang Q, Deng Y et al (2022) Analysis of cf-mtDNA and cf-nDNA fragment size distribution using different isolation methods in BV-2 cell supernatant of starvation-induced autophagy. Biochimica et Biophys Acta (BBA) - Mol Cell Res 1869:119147. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119147","journal-title":"Biochimica et Biophys Acta (BBA) - Mol Cell Res"},{"key":"2317_CR56","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1158\/1078-0432.CCR-19-3015","volume":"26","author":"SR Greytak","year":"2020","unstructured":"Greytak SR, Engel KB, Parpart-Li S et al (2020) Harmonizing cell-free DNA collection and processing practices through evidence-based guidance. Clin Cancer Res 26:3104\u20133109. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3015","journal-title":"Clin Cancer Res"},{"key":"2317_CR57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.tig.2021.04.005","volume":"37","author":"DSC Han","year":"2021","unstructured":"Han DSC, Lo YMD (2021) The nexus of cfDNA and nuclease biology. Trends Genet 37:758\u2013770","journal-title":"Trends Genet"},{"key":"2317_CR58","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27:954\u2013963","journal-title":"Nat Med"},{"key":"2317_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/DNND.S98936","volume":"7","author":"V Harris","year":"2017","unstructured":"Harris V, Tuddenham J, Sadiq S (2017) Biomarkers of multiple sclerosis: current findings. Degener Neurol Neuromuscul Dis 7:19\u201329. https:\/\/doi.org\/10.2147\/DNND.S98936","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"2317_CR60","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.molmed.2020.01.012","volume":"26","author":"E Heitzer","year":"2020","unstructured":"Heitzer E, Auinger L, Speicher MR (2020) Cell-free DNA and apoptosis: how dead cells inform about the living. Trends Mol Med 26:519\u2013528. https:\/\/doi.org\/10.1016\/j.molmed.2020.01.012","journal-title":"Trends Mol Med"},{"key":"2317_CR61","doi-asserted-by":"publisher","first-page":"101688","DOI":"10.1016\/j.tranon.2023.101688","volume":"33","author":"RA Hickman","year":"2023","unstructured":"Hickman RA, Miller AM, Arcila ME (2023) Cerebrospinal fluid: a unique source of circulating tumor DNA with broad clinical applications. Transl Oncol 33:101688. https:\/\/doi.org\/10.1016\/j.tranon.2023.101688","journal-title":"Transl Oncol"},{"key":"2317_CR62","doi-asserted-by":"publisher","unstructured":"Hochreiter-Hufford A, Ravichandran KS (2013) Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol 5. https:\/\/doi.org\/10.1101\/cshperspect.a008748","DOI":"10.1101\/cshperspect.a008748"},{"key":"2317_CR63","doi-asserted-by":"publisher","first-page":"103166","DOI":"10.1016\/j.critrevonc.2020.103166","volume":"157","author":"Z Hu","year":"2021","unstructured":"Hu Z, Chen H, Long Y et al (2021) The main sources of circulating cell-free DNA: apoptosis, necrosis and active secretion. Crit Rev Oncol Hematol 157:103166. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103166","journal-title":"Crit Rev Oncol Hematol"},{"key":"2317_CR64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-94-017-9168-7_11","volume":"5","author":"L Hui","year":"2015","unstructured":"Hui L, Maron JL, Gahan PB (2015) Other body fluids as non-invasive sources of cell-free DNA\/RNA. Adv Predict, Prevent Personalised Med 5:295\u2013323. https:\/\/doi.org\/10.1007\/978-94-017-9168-7_11","journal-title":"Adv Predict, Prevent Personalised Med"},{"key":"2317_CR65","doi-asserted-by":"publisher","unstructured":"Hummel EM, Hessas E, M\u00fcller S, et al (2018) Cell-free DNA release under psychosocial and physical stress conditions. Transl Psychiatry 8. https:\/\/doi.org\/10.1038\/s41398-018-0264-x","DOI":"10.1038\/s41398-018-0264-x"},{"key":"2317_CR66","doi-asserted-by":"publisher","first-page":"420","DOI":"10.21037\/tlcr.2016.08.06","volume":"5","author":"M Ili\u00e9","year":"2016","unstructured":"Ili\u00e9 M, Hofman P (2016) Pros: can tissue biopsy be replaced by liquid biopsy? Transl Lung Cancer Res 5:420\u2013423. https:\/\/doi.org\/10.21037\/tlcr.2016.08.06","journal-title":"Transl Lung Cancer Res"},{"key":"2317_CR67","doi-asserted-by":"publisher","unstructured":"Iser F, Hinz F, Hoffmann DC, et al (2024) Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma. Clin Cancer Res OF1\u2013OF12. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-2907","DOI":"10.1158\/1078-0432.CCR-23-2907"},{"issue":"4","key":"2317_CR68","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61(4):1659\u201365","journal-title":"Cancer Res"},{"key":"2317_CR69","doi-asserted-by":"publisher","unstructured":"Janku F, Huang HJ, Pereira DY, et al (2021) A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA. Sci Rep 11. https:\/\/doi.org\/10.1038\/s41598-021-98815-x","DOI":"10.1038\/s41598-021-98815-x"},{"key":"2317_CR70","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/brain\/awad325","volume":"147","author":"ME Johansson","year":"2024","unstructured":"Johansson ME, Toni I, Kessels RPC et al (2024) Clinical severity in Parkinson\u2019s disease is determined by decline in cortical compensation. Brain 147:871\u2013886. https:\/\/doi.org\/10.1093\/brain\/awad325","journal-title":"Brain"},{"key":"2317_CR71","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cca.2010.07.032","volume":"411","author":"K Jung","year":"2010","unstructured":"Jung K, Fleischhacker M, Rabien A (2010) Cell-free DNA in the blood as a solid tumor biomarker\u2014a critical appraisal of the literature. Clin Chim Acta 411:1611\u20131624. https:\/\/doi.org\/10.1016\/j.cca.2010.07.032","journal-title":"Clin Chim Acta"},{"key":"2317_CR72","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert C, Melo SA, Protopopov A et al (2014) Identification of doublestranded genomic DNA spanning all chromosomes with mutated KRAS and P53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289:3869\u20133875. https:\/\/doi.org\/10.1074\/jbc.C113.532267","journal-title":"J Biol Chem"},{"key":"2317_CR73","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1038\/s41598-019-39848-1","volume":"9","author":"S Kayhanian","year":"2019","unstructured":"Kayhanian S, Young AMH, Ewen RL et al (2019) Thresholds for identifying pathological intracranial pressure in paediatric traumatic brain injury. Sci Rep 9:3537. https:\/\/doi.org\/10.1038\/s41598-019-39848-1","journal-title":"Sci Rep"},{"issue":"1","key":"2317_CR74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13148-021-01182-7","volume":"13","author":"MA Kerachian","year":"2021","unstructured":"Kerachian MA, Azghandi M, Mozaffari-Jovin S, Thierry AR (2021) Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA. Clin Epigenetics 13(1):193. https:\/\/doi.org\/10.1186\/s13148-021-01182-7","journal-title":"Clin Epigenetics"},{"key":"2317_CR75","doi-asserted-by":"publisher","unstructured":"Khemka S, Sehar U, Manna PR, et al (2024) Cell-free DNA as peripheral biomarker of Alzheimer\u2019s disease. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2024.0329","DOI":"10.14336\/ad.2024.0329"},{"key":"2317_CR76","doi-asserted-by":"publisher","unstructured":"Khurram I, Khan MU, Ibrahim S, et al (2023) Efficacy of cell-free DNA as a diagnostic biomarker in breast cancer patients. Sci Rep 13. https:\/\/doi.org\/10.1038\/s41598-023-42726-6","DOI":"10.1038\/s41598-023-42726-6"},{"key":"2317_CR77","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1007\/s13277-016-5035-9","volume":"37","author":"Y Kiraz","year":"2016","unstructured":"Kiraz Y, Adan A, Kartal Yandim M, Baran Y (2016) Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biology 37:8471\u20138486","journal-title":"Tumor Biology"},{"key":"2317_CR78","doi-asserted-by":"publisher","first-page":"e00292","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C et al (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21:e00292. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002","journal-title":"Neurotherapeutics"},{"key":"2317_CR79","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","volume":"72","author":"GG Kovacs","year":"2019","unstructured":"Kovacs GG (2019) Molecular pathology of neurodegenerative diseases: principles and practice. J Clin Pathol 72:725\u2013735. https:\/\/doi.org\/10.1136\/jclinpath-2019-205952","journal-title":"J Clin Pathol"},{"key":"2317_CR80","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","volume":"20","author":"A Kustanovich","year":"2019","unstructured":"Kustanovich A, Schwartz R, Peretz T, Grinshpun A (2019) Life and death of circulating cell-free DNA. Cancer Biol Ther 20:1057\u20131067. https:\/\/doi.org\/10.1080\/15384047.2019.1598759","journal-title":"Cancer Biol Ther"},{"key":"2317_CR81","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/diagnostics14060585","volume":"14","author":"J Lee","year":"2024","unstructured":"Lee J, Renslo J, Wong K et al (2024) Current trends and applications of PET\/MRI hybrid imaging in neurodegenerative diseases and normal aging. Diagnostics 14:585. https:\/\/doi.org\/10.3390\/diagnostics14060585","journal-title":"Diagnostics"},{"key":"2317_CR82","first-page":"646","volume":"37","author":"SA Leon","year":"1977","unstructured":"Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646\u2013650","journal-title":"Cancer Res"},{"key":"2317_CR83","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1373\/clinchem.2016.260331","volume":"62","author":"F Leung","year":"2016","unstructured":"Leung F, Kulasingam V, Diamandis EP et al (2016) Circulating tumor DNA as a cancer biomarker: fact or fiction? Clin Chem 62:1054\u20131060. https:\/\/doi.org\/10.1373\/clinchem.2016.260331","journal-title":"Clin Chem"},{"key":"2317_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16493","author":"J Li","year":"2024","unstructured":"Li J, Gao C, Wang Q et al (2024) Elevated serum circulating cell-free mitochondrial DNA in amyotrophic lateral sclerosis. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.16493","journal-title":"Eur J Neurol"},{"key":"2317_CR85","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1016\/j.acra.2024.03.019","volume":"31","author":"K Li","year":"2024","unstructured":"Li K, Zhu Q, Yang J et al (2024) Imaging and liquid biopsy for distinguishing true progression from pseudoprogression in gliomas, current advances and challenges. Acad Radiol 31:3366\u20133383. https:\/\/doi.org\/10.1016\/j.acra.2024.03.019","journal-title":"Acad Radiol"},{"key":"2317_CR86","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11604-024-01535-1","volume":"42","author":"X Liang","year":"2024","unstructured":"Liang X, Yan Z, Li Y (2024) Exploring subtypes of multiple sclerosis through unsupervised machine learning of automated fiber quantification. Jpn J Radiol 42:581\u2013589. https:\/\/doi.org\/10.1007\/s11604-024-01535-1","journal-title":"Jpn J Radiol"},{"key":"2317_CR87","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S2468-1253(23)00146-2","volume":"8","author":"M Loft","year":"2023","unstructured":"Loft M, To YH, Gibbs P, Tie J (2023) Clinical application of circulating tumour DNA in colorectal cancer. Lancet Gastroenterol Hepatol 8:837\u2013852. https:\/\/doi.org\/10.1016\/S2468-1253(23)00146-2","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2317_CR88","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.mito.2018.07.008","volume":"46","author":"H Lowes","year":"2019","unstructured":"Lowes H, Pyle A, Duddy M, Hudson G (2019) Cell-free mitochondrial DNA in progressive multiple sclerosis. Mitochondrion 46:307\u2013312. https:\/\/doi.org\/10.1016\/j.mito.2018.07.008","journal-title":"Mitochondrion"},{"key":"2317_CR89","doi-asserted-by":"publisher","unstructured":"Lowes H, Pyle A, Santibanez-Koref M, Hudson G (2020) Circulating cell-free mitochondrial DNA levels in Parkinson\u2019s disease are influenced by treatment. Mol Neurodegener 15. https:\/\/doi.org\/10.1186\/s13024-020-00362-y","DOI":"10.1186\/s13024-020-00362-y"},{"key":"2317_CR90","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-bioeng-110222-111259","volume":"26","author":"C Loy","year":"2024","unstructured":"Loy C, Ahmann L, De Vlaminck I, Gu W (2024) Liquid biopsy based on cell-free DNA and RNA. Annu Rev Biomed Eng 26:169\u2013195. https:\/\/doi.org\/10.1146\/annurev-bioeng-110222-111259","journal-title":"Annu Rev Biomed Eng"},{"key":"2317_CR91","doi-asserted-by":"publisher","unstructured":"Ma Y, Wang Y, He L, et al (2024) Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non-small cell lung cancer patients. Cancer Med 13. https:\/\/doi.org\/10.1002\/cam4.70197","DOI":"10.1002\/cam4.70197"},{"key":"2317_CR92","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.3390\/cells12232679","volume":"12","author":"M Mac\u00edas","year":"2023","unstructured":"Mac\u00edas M, Acha B, Corroza J et al (2023) Liquid biopsy in Alzheimer\u2019s disease patients reveals epigenetic changes in the PRLHR gene. Cells 12:2679. https:\/\/doi.org\/10.3390\/cells12232679","journal-title":"Cells"},{"key":"2317_CR93","doi-asserted-by":"publisher","unstructured":"Mac\u00edas M, Alba-Linares JJ, Acha B, Blanco-Luquin I, Fern\u00e1ndez AF, \u00c1lvarez-Jim\u00e9nez J, Mendioroz M (2024) Towards a personalized medicine through liquid biopsy in alzheimer\u2019s disease: epigenome of cell-free DNA reveals methylation differences linked to APOE status. https:\/\/doi.org\/10.21203\/rs.3.rs-5358927\/v1","DOI":"10.21203\/rs.3.rs-5358927\/v1"},{"issue":"3","key":"2317_CR94","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41416-021-01594-5","volume":"126","author":"R Mair","year":"2021","unstructured":"Mair R, Mouliere F (2021) Cell-free DNA technologies for the analysis of brain cancer. Br J Cancer 126(3):371\u2013378","journal-title":"Br J Cancer"},{"key":"2317_CR95","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3390\/cells12141911","volume":"12","author":"S Malhotra","year":"2023","unstructured":"Malhotra S, Miras MCM, Pappolla A et al (2023) Liquid Biopsy in Neurological Diseases. Cells 12:1911. https:\/\/doi.org\/10.3390\/cells12141911","journal-title":"Cells"},{"key":"2317_CR96","first-page":"241","volume":"142","author":"P Mandel","year":"1948","unstructured":"Mandel P (1948) Les acides nucleiques du plasma sanguin chez 1 homme. CR Seances Soc Biol Fil 142:241\u2013243","journal-title":"CR Seances Soc Biol Fil"},{"key":"2317_CR97","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27:1918\u20131929. https:\/\/doi.org\/10.1111\/ene.14393","journal-title":"Eur J Neurol"},{"key":"2317_CR98","doi-asserted-by":"publisher","unstructured":"McEwen AE, Leary SES, Lockwood CM (2020) Beyond the blood: CSF-derived cfDNA for diagnosis and characterization of CNS tumors. Front Cell Dev Biol 8. https:\/\/doi.org\/10.3389\/fcell.2020.00045","DOI":"10.3389\/fcell.2020.00045"},{"key":"2317_CR99","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1101\/gad.14.5.549","volume":"14","author":"D McIlroy","year":"2000","unstructured":"McIlroy D, Tanaka M, Sakahira H et al (2000) An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes. Genes Dev 14:549\u2013558. https:\/\/doi.org\/10.1101\/gad.14.5.549","journal-title":"Genes Dev"},{"key":"2317_CR100","doi-asserted-by":"publisher","first-page":"e006013","DOI":"10.1136\/jitc-2022-006013","volume":"11","author":"JE Medina","year":"2023","unstructured":"Medina JE, Dracopoli NC, Bach PB et al (2023) Cell-free DNA approaches for cancer early detection and interception. J Immunother Cancer 11:e006013. https:\/\/doi.org\/10.1136\/jitc-2022-006013","journal-title":"J Immunother Cancer"},{"key":"2317_CR101","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2217\/epi-2021-0176","volume":"13","author":"J Meng","year":"2021","unstructured":"Meng J, Wang F, Ji L et al (2021) Comprehensive methylation profile of CSF cf DNA revealed pathogenesis and diagnostic markers for early-onset Parkinson\u2019s disease. Epigenomics 13:1637\u20131651. https:\/\/doi.org\/10.2217\/epi-2021-0176","journal-title":"Epigenomics"},{"key":"2317_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/14737159.2021.1860759","volume":"21","author":"A Moreno-Manuel","year":"2021","unstructured":"Moreno-Manuel A, Calabuig-Fari\u00f1as S, Obrador-Hevia A et al (2021) dPCR application in liquid biopsies: divide and conquer. Expert Rev Mol Diagn 21:3\u201315. https:\/\/doi.org\/10.1080\/14737159.2021.1860759","journal-title":"Expert Rev Mol Diagn"},{"key":"2317_CR103","doi-asserted-by":"publisher","unstructured":"Mouliere F, Chandrananda D, Piskorz AM, et al (2018) Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med 10. https:\/\/doi.org\/10.1126\/scitranslmed.aat4921","DOI":"10.1126\/scitranslmed.aat4921"},{"key":"2317_CR104","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jmoldx.2023.11.007","volume":"26","author":"S Naegele","year":"2024","unstructured":"Naegele S, Ruiz-Torres DA, Zhao Y et al (2024) Comparing the diagnostic performance of quantitative PCR, digital droplet PCR, and next-generation sequencing liquid biopsies for human papillomavirus\u2013associated cancers. J Mol Diagn 26:179\u2013190. https:\/\/doi.org\/10.1016\/j.jmoldx.2023.11.007","journal-title":"J Mol Diagn"},{"key":"2317_CR105","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1006\/excr.2000.4834","volume":"256","author":"S Nagata","year":"2000","unstructured":"Nagata S (2000) Apoptotic DNA fragmentation. Exp Cell Res 256:12\u201318. https:\/\/doi.org\/10.1006\/excr.2000.4834","journal-title":"Exp Cell Res"},{"key":"2317_CR106","doi-asserted-by":"publisher","first-page":"577107","DOI":"10.1016\/j.jneuroim.2019.577107","volume":"338","author":"M Nasi","year":"2020","unstructured":"Nasi M, Bianchini E, De Biasi S et al (2020) Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis. J Neuroimmunol 338:577107. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577107","journal-title":"J Neuroimmunol"},{"key":"2317_CR107","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s44222-023-00050-8","volume":"1","author":"A Natalia","year":"2023","unstructured":"Natalia A, Zhang L, Sundah NR et al (2023) Analytical device miniaturization for the detection of circulating biomarkers. Nat Rev Bioeng 1:481\u2013498. https:\/\/doi.org\/10.1038\/s44222-023-00050-8","journal-title":"Nat Rev Bioeng"},{"key":"2317_CR108","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-biochem-032620-104401","volume":"92","author":"LE Newman","year":"2023","unstructured":"Newman LE, Shadel GS (2023) Mitochondrial DNA release in innate immune signaling. Annu Rev Biochem 92:299\u2013332. https:\/\/doi.org\/10.1146\/annurev-biochem-032620-104401","journal-title":"Annu Rev Biochem"},{"key":"2317_CR109","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/ADR-240012","volume":"8","author":"M Nguyen","year":"2024","unstructured":"Nguyen M, Wood C, Rios A et al (2024) Circulating cell free DNA and DNA double-strand breakage in Alzheimer\u2019s disease. J Alzheimers Dis Rep 8:627\u2013635. https:\/\/doi.org\/10.3233\/ADR-240012","journal-title":"J Alzheimers Dis Rep"},{"key":"2317_CR110","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1038\/sj.onc.1207532","volume":"23","author":"CJ Norbury","year":"2004","unstructured":"Norbury CJ, Zhivotovsky B (2004) DNA damage-induced apoptosis. Oncogene 23:2797\u20132808","journal-title":"Oncogene"},{"key":"2317_CR111","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/nu13041362","volume":"13","author":"NG Norwitz","year":"2021","unstructured":"Norwitz NG, Saif N, Ariza IE, Isaacson RS (2021) Precision nutrition for Alzheimer\u2019s prevention in ApoE4 carriers. Nutrients 13:1362. https:\/\/doi.org\/10.3390\/nu13041362","journal-title":"Nutrients"},{"key":"2317_CR112","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/cancers16051009","volume":"16","author":"R Otsuji","year":"2024","unstructured":"Otsuji R, Fujioka Y, Hata N et al (2024) Liquid biopsy for glioma using cell-free DNA in cerebrospinal fluid. Cancers (Basel) 16:1009. https:\/\/doi.org\/10.3390\/cancers16051009","journal-title":"Cancers (Basel)"},{"key":"2317_CR113","doi-asserted-by":"publisher","first-page":"175883591879463","DOI":"10.1177\/1758835918794630","volume":"10","author":"R Palmirotta","year":"2018","unstructured":"Palmirotta R, Lovero D, Cafforio P et al (2018) Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol 10:175883591879463. https:\/\/doi.org\/10.1177\/1758835918794630","journal-title":"Ther Adv Med Oncol"},{"key":"2317_CR114","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/antiox13020240","volume":"13","author":"C Peggion","year":"2024","unstructured":"Peggion C, Cal\u00ec T, Brini M (2024) Mitochondria dysfunction and neuroinflammation in neurodegeneration: who comes first? Antioxidants 13:240. https:\/\/doi.org\/10.3390\/antiox13020240","journal-title":"Antioxidants"},{"key":"2317_CR115","doi-asserted-by":"publisher","unstructured":"Peng H, Pan M, Zhou Z, et al (2024) The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples. Front Cell Dev Biol 12. https:\/\/doi.org\/10.3389\/fcell.2024.1385041","DOI":"10.3389\/fcell.2024.1385041"},{"key":"2317_CR116","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2024) Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev 104:103\u2013197. https:\/\/doi.org\/10.1152\/physrev.00030.2022","journal-title":"Physiol Rev"},{"key":"2317_CR117","doi-asserted-by":"publisher","unstructured":"Pingle SC, Lin F, Anekoji MS, et al (2023) Exploring the role of cerebrospinal fluid as analyte in neurologic disorders. Future Sci OA 9. https:\/\/doi.org\/10.2144\/fsoa-2023-0006","DOI":"10.2144\/fsoa-2023-0006"},{"key":"2317_CR118","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.23955","volume":"74","author":"P Podlesniy","year":"2013","unstructured":"Podlesniy P, Figueiro-Silva J, Llado A et al (2013) Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol 74:655\u2013668. https:\/\/doi.org\/10.1002\/ana.23955","journal-title":"Ann Neurol"},{"key":"2317_CR119","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.3390\/diagnostics12102550","volume":"12","author":"E Polatoglou","year":"2022","unstructured":"Polatoglou E, Mayer Z, Ungerer V et al (2022) Isolation and quantification of plasma cell-free DNA using different manual and automated methods. Diagnostics 12:2550. https:\/\/doi.org\/10.3390\/diagnostics12102550","journal-title":"Diagnostics"},{"key":"2317_CR120","doi-asserted-by":"publisher","unstructured":"Pollard C, Aston K, Emery BR, et al (2023) Detection of neuron-derived cfDNA in blood plasma: a new diagnostic approach for neurodegenerative conditions. Front Neurol 14. https:\/\/doi.org\/10.3389\/fneur.2023.1272960","DOI":"10.3389\/fneur.2023.1272960"},{"key":"2317_CR121","doi-asserted-by":"publisher","first-page":"105885","DOI":"10.1016\/j.nbd.2022.105885","volume":"174","author":"M Puigr\u00f2s","year":"2022","unstructured":"Puigr\u00f2s M, Calderon A, P\u00e9rez-Soriano A et al (2022) Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2. Parkinson\u2019s Dis Neurobiol Dis 174:105885. https:\/\/doi.org\/10.1016\/j.nbd.2022.105885","journal-title":"Parkinson\u2019s Dis Neurobiol Dis"},{"key":"2317_CR122","doi-asserted-by":"crossref","unstructured":"Ranucci R (2019) Cell-free DNA: applications in different diseases. In: Methods in molecular biology. Humana Press Inc., 3\u201312","DOI":"10.1007\/978-1-4939-8973-7_1"},{"key":"2317_CR123","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.csbj.2016.05.004","volume":"14","author":"S Rapisuwon","year":"2016","unstructured":"Rapisuwon S, Vietsch EE, Wellstein A (2016) Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J 14:211\u2013222. https:\/\/doi.org\/10.1016\/j.csbj.2016.05.004","journal-title":"Comput Struct Biotechnol J"},{"key":"2317_CR124","doi-asserted-by":"publisher","first-page":"102410","DOI":"10.1016\/j.arr.2024.102410","volume":"99","author":"A Reddy","year":"2024","unstructured":"Reddy A, Reddy RP, Roghani AK et al (2024) Artificial intelligence in Parkinson\u2019s disease: early detection and diagnostic advancements. Ageing Res Rev 99:102410. https:\/\/doi.org\/10.1016\/j.arr.2024.102410","journal-title":"Ageing Res Rev"},{"key":"2317_CR125","doi-asserted-by":"crossref","unstructured":"Risi B, Imarisio A, Cuconato G, Padovani A, Valente EM, Filosto M (2025) Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: a systematic review.\u00a0Eur J Neurol\u00a032(1):e70014","DOI":"10.1111\/ene.70014"},{"key":"2317_CR126","doi-asserted-by":"publisher","first-page":"135813","DOI":"10.1016\/j.neulet.2021.135813","volume":"750","author":"P-P Robichaud","year":"2021","unstructured":"Robichaud P-P, Arseneault M, O\u2019Connell C et al (2021) Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis. Neurosci Lett 750:135813. https:\/\/doi.org\/10.1016\/j.neulet.2021.135813","journal-title":"Neurosci Lett"},{"key":"2317_CR127","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1373\/clinchem.2007.101030","volume":"54","author":"K Saukkonen","year":"2008","unstructured":"Saukkonen K, Lakkisto P, Pettil\u00e4 V et al (2008) Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 54:1000\u20131007. https:\/\/doi.org\/10.1373\/clinchem.2007.101030","journal-title":"Clin Chem"},{"key":"2317_CR128","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/35037722","volume":"407","author":"J Savill","year":"2000","unstructured":"Savill J, Fadok V (2000) Corpse clearance defines the meaning of cell death. Nature 407:784\u2013788. https:\/\/doi.org\/10.1038\/35037722","journal-title":"Nature"},{"key":"2317_CR129","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1093\/humrep\/deab206","volume":"36","author":"G Schobers","year":"2021","unstructured":"Schobers G, Koeck R, Pellaers D et al (2021) Liquid biopsy: state of reproductive medicine and beyond. Hum Reprod 36:2824\u20132839. https:\/\/doi.org\/10.1093\/humrep\/deab206","journal-title":"Hum Reprod"},{"key":"2317_CR130","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DSB, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426\u2013437. https:\/\/doi.org\/10.1038\/nrc3066","journal-title":"Nat Rev Cancer"},{"key":"2317_CR131","doi-asserted-by":"crossref","unstructured":"\u0160est\u00e1kov\u00e1 \u0160, \u0160\u00e1lek C, Reme\u0161ov\u00e1 H (2019) DNA methylation validation methods: a coherent review with practical comparison.\u00a0Biol Proced Online\u00a021:1\u201311","DOI":"10.1186\/s12575-019-0107-z"},{"key":"2317_CR132","doi-asserted-by":"publisher","unstructured":"Siejka-Zieli\u0144ska P, Cheng J, Jackson F, et al (2021) Cell-free DNA TAPS provides multimodal information for early cancer detection. Sci Adv 7. https:\/\/doi.org\/10.1126\/sciadv.abh0534","DOI":"10.1126\/sciadv.abh0534"},{"key":"2317_CR133","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41551-021-00837-3","volume":"6","author":"P Song","year":"2022","unstructured":"Song P, Wu LR, Yan YH et al (2022) Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics. Nat Biomed Eng 6:232\u2013245","journal-title":"Nat Biomed Eng"},{"key":"2317_CR134","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40291-019-00442-w","volume":"24","author":"L Sorber","year":"2020","unstructured":"Sorber L, Zwaenepoel K, Jacobs J et al (2020) Specialized blood collection tubes for liquid biopsy: improving the pre-analytical conditions. Mol Diagn Ther 24:113\u2013124. https:\/\/doi.org\/10.1007\/s40291-019-00442-w","journal-title":"Mol Diagn Ther"},{"key":"2317_CR135","doi-asserted-by":"publisher","first-page":"e0291285","DOI":"10.1371\/journal.pone.0291285","volume":"19","author":"V Srinivasan","year":"2024","unstructured":"Srinivasan V, Homer V, Barton D et al (2024) A low molecular weight dextran sulphate, ILB\u00ae, for the treatment of amyotrophic lateral sclerosis (ALS): an open-label, single-arm, single-centre, phase II trial. PLoS ONE 19:e0291285. https:\/\/doi.org\/10.1371\/journal.pone.0291285","journal-title":"PLoS ONE"},{"key":"2317_CR136","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0009-8981(01)00665-9","volume":"313","author":"M Stroun","year":"2001","unstructured":"Stroun M, Lyautey J, Lederrey C et al (2001) About the possible origin and mechanism of circulating DNA. Clin Chim Acta 313:139\u2013142. https:\/\/doi.org\/10.1016\/S0009-8981(01)00665-9","journal-title":"Clin Chim Acta"},{"key":"2317_CR137","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/embo-reports\/kvf138","volume":"3","author":"P Syntichaki","year":"2002","unstructured":"Syntichaki P, Tavernarakis N (2002) Death by necrosis. EMBO Rep 3:604\u2013609. https:\/\/doi.org\/10.1093\/embo-reports\/kvf138","journal-title":"EMBO Rep"},{"issue":"11","key":"2317_CR138","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI105479","volume":"45","author":"EM Tan","year":"1966","unstructured":"Tan EM, Schur PH, Carr RI, Kunkel H (1966) Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45(11):1732\u20131740","journal-title":"J Clin Invest"},{"issue":"6","key":"2317_CR139","doi-asserted-by":"publisher","first-page":"104404","DOI":"10.1016\/j.isci.2022.104404","volume":"25","author":"HY Tan","year":"2022","unstructured":"Tan HY, Yong YK, Xue YC et al (2022) cGAS and DDX41-STING mediated intrinsic immunity spreads intercellularly to promote neuroinflammation in SOD1 ALS model. iScience 25(6):104404. https:\/\/doi.org\/10.1016\/j.isci.2022.104404","journal-title":"iScience"},{"key":"2317_CR140","doi-asserted-by":"publisher","first-page":"101246","DOI":"10.1016\/j.ijcha.2023.101246","volume":"47","author":"E Tan","year":"2023","unstructured":"Tan E, Liu D, Perry L et al (2023) Cell-free DNA as a potential biomarker for acute myocardial infarction: a systematic review and meta-analysis. IJC Heart Vasc 47:101246. https:\/\/doi.org\/10.1016\/j.ijcha.2023.101246","journal-title":"IJC Heart Vasc"},{"key":"2317_CR141","doi-asserted-by":"publisher","first-page":"a024539","DOI":"10.1101\/cshperspect.a024539","volume":"7","author":"J Tcw","year":"2017","unstructured":"Tcw J, Goate AM (2017) Genetics of \u03b2-amyloid precursor protein in Alzheimer\u2019s disease. Cold Spring Harb Perspect Med 7:a024539. https:\/\/doi.org\/10.1101\/cshperspect.a024539","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2317_CR142","doi-asserted-by":"publisher","unstructured":"Teo YV, Capri M, Morsiani C, et al (2019) Cell\u2010free DNA as a biomarker of aging. Aging Cell 18. https:\/\/doi.org\/10.1111\/acel.12890","DOI":"10.1111\/acel.12890"},{"key":"2317_CR143","doi-asserted-by":"publisher","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18. https:\/\/doi.org\/10.1111\/acel.13031","DOI":"10.1111\/acel.13031"},{"key":"2317_CR144","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1182\/bloodadvances.2018018895","volume":"3","author":"AJ Van der Meer","year":"2019","unstructured":"Van der Meer AJ, Kroeze A, Hoogendijk AJ et al (2019) Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans. Blood Adv 3:724\u2013728. https:\/\/doi.org\/10.1182\/bloodadvances.2018018895","journal-title":"Blood Adv"},{"key":"2317_CR145","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/clinchem\/hvac029","volume":"68","author":"Y Van der Pol","year":"2022","unstructured":"Van der Pol Y, Moldovan N, Verkuijlen S et al (2022) The effect of preanalytical and physiological variables on cell-free DNA fragmentation. Clin Chem 68:803\u2013813. https:\/\/doi.org\/10.1093\/clinchem\/hvac029","journal-title":"Clin Chem"},{"key":"2317_CR146","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1365-2141.1994.tb04828.x","volume":"86","author":"V Vasioukhin","year":"1994","unstructured":"Vasioukhin V, Anker P, Maurice P et al (1994) Point mutations of the N- ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 86:774\u2013779. https:\/\/doi.org\/10.1111\/j.1365-2141.1994.tb04828.x","journal-title":"Br J Haematol"},{"key":"2317_CR147","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/FTD.0000000000000549","volume":"40","author":"JGHP Verhoeven","year":"2018","unstructured":"Verhoeven JGHP, Boer K, Van Schaik RHN et al (2018) Liquid biopsies to monitor solid organ transplant function: a review of new biomarkers. Ther Drug Monit 40:515\u2013525. https:\/\/doi.org\/10.1097\/FTD.0000000000000549","journal-title":"Ther Drug Monit"},{"key":"2317_CR148","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.clim.2006.07.012","volume":"122","author":"ICB Viorritto","year":"2007","unstructured":"Viorritto ICB, Nikolov NP, Siegel RM (2007) Autoimmunity versus tolerance: can dying cells tip the balance? Clin Immunol 122:125\u2013134. https:\/\/doi.org\/10.1016\/j.clim.2006.07.012","journal-title":"Clin Immunol"},{"key":"2317_CR149","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1007\/s00415-024-12220-8","volume":"271","author":"S Voigtlaender","year":"2024","unstructured":"Voigtlaender S, Pawelczyk J, Geiger M et al (2024) Artificial intelligence in neurology: opportunities, challenges, and policy implications. J Neurol 271:2258\u20132273","journal-title":"J Neurol"},{"key":"2317_CR150","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","volume":"14","author":"S Volik","year":"2016","unstructured":"Volik S, Alcaide M, Morin RD, Collins C (2016) Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies. Mol Cancer Res 14:898\u2013908. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0044","journal-title":"Mol Cancer Res"},{"key":"2317_CR151","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jalm\/jfad103","volume":"9","author":"LM Wainman","year":"2024","unstructured":"Wainman LM, Sathyanarayana SH, Lefferts JA (2024) Applications of digital polymerase chain reaction (dPCR) in molecular and clinical testing. J Appl Lab Med 9:124\u2013137. https:\/\/doi.org\/10.1093\/jalm\/jfad103","journal-title":"J Appl Lab Med"},{"key":"2317_CR152","doi-asserted-by":"publisher","first-page":"43180","DOI":"10.18632\/oncotarget.17858","volume":"8","author":"W Wang","year":"2017","unstructured":"Wang W, Kong P, Ma G et al (2017) Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget 8:43180\u201343191. https:\/\/doi.org\/10.18632\/oncotarget.17858","journal-title":"Oncotarget"},{"key":"2317_CR153","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.12688\/f1000research.14506.1","volume":"7","author":"J Weller","year":"2018","unstructured":"Weller J, Budson A (2018) Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res 7:1161. https:\/\/doi.org\/10.12688\/f1000research.14506.1","journal-title":"F1000Res"},{"key":"2317_CR154","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cca.2017.12.009","volume":"477","author":"E Wieczorek","year":"2018","unstructured":"Wieczorek E, Reszka E (2018) mRNA, microRNA and lncRNA as novel bladder tumor markers. Clin Chim Acta 477:141\u2013153. https:\/\/doi.org\/10.1016\/j.cca.2017.12.009","journal-title":"Clin Chim Acta"},{"key":"2317_CR155","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3390\/ijms25052818","volume":"25","author":"M Wojtkowska","year":"2024","unstructured":"Wojtkowska M, Karczewska N, Pacewicz K et al (2024) Quantification of circulating cell-free DNA in idiopathic Parkinson\u2019s disease patients. Int J Mol Sci 25:2818. https:\/\/doi.org\/10.3390\/ijms25052818","journal-title":"Int J Mol Sci"},{"key":"2317_CR156","doi-asserted-by":"publisher","unstructured":"Wong SQ, Li J, Tan AYC, et al (2014) Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genomics 7. https:\/\/doi.org\/10.1186\/1755-8794-7-23","DOI":"10.1186\/1755-8794-7-23"},{"key":"2317_CR157","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/path.1711420112","volume":"142","author":"AH Wyllie","year":"1984","unstructured":"Wyllie AH, Morris RG, Smith AL, Dunlop D (1984) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67\u201377. https:\/\/doi.org\/10.1002\/path.1711420112","journal-title":"J Pathol"},{"key":"2317_CR158","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.plrev.2024.03.007","volume":"49","author":"L Xie","year":"2024","unstructured":"Xie L, Zhao J, Li Y, Bai J (2024) PET brain imaging in neurological disorders. Phys Life Rev 49:100\u2013111. https:\/\/doi.org\/10.1016\/j.plrev.2024.03.007","journal-title":"Phys Life Rev"},{"key":"2317_CR159","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/mi10100672","volume":"10","author":"Z Xu","year":"2019","unstructured":"Xu Z, Qiao Y, Tu J (2019) Microfluidic technologies for cfDNA isolation and analysis. Micromachines (Basel) 10:672. https:\/\/doi.org\/10.3390\/mi10100672","journal-title":"Micromachines (Basel)"},{"key":"2317_CR160","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.gene.2016.06.033","volume":"590","author":"W Yao","year":"2016","unstructured":"Yao W, Mei C, Nan X, Hui L (2016) Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study. Gene 590:142\u2013148. https:\/\/doi.org\/10.1016\/j.gene.2016.06.033","journal-title":"Gene"},{"key":"2317_CR161","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/br.2024.1800","volume":"21","author":"F Zamuner","year":"2024","unstructured":"Zamuner F, Ramos-l\u00f3pez A, Garc\u00eda-Negr\u00f3n A et al (2024) Evaluation of silica spin-column and magnetic bead formats for rapid DNA methylation analysis in clinical and point-of-care settings. Biomed Rep 21:112. https:\/\/doi.org\/10.3892\/br.2024.1800","journal-title":"Biomed Rep"},{"key":"2317_CR162","doi-asserted-by":"publisher","unstructured":"Zemmour H, Planer D, Magenheim J, et al (2018) Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA. Nat Commun 9. https:\/\/doi.org\/10.1038\/s41467-018-03961-y","DOI":"10.1038\/s41467-018-03961-y"},{"key":"2317_CR163","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/00365513.2022.2100272","volume":"82","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhou D, Li S et al (2022) Performance of ImproGene cfDNA blood collection tubes for mutation analysis in cancer patients. Scand J Clin Lab Invest 82:378\u2013384. https:\/\/doi.org\/10.1080\/00365513.2022.2100272","journal-title":"Scand J Clin Lab Invest"},{"key":"2317_CR164","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/diagnostics14101045","volume":"14","author":"P Zhong","year":"2024","unstructured":"Zhong P, Bai L, Hong M et al (2024) A comprehensive review on circulating cfRNA in plasma: implications for disease diagnosis and beyond. Diagnostics 14:1045. https:\/\/doi.org\/10.3390\/diagnostics14101045","journal-title":"Diagnostics"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02317-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-025-02317-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02317-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T11:02:35Z","timestamp":1743678155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-025-02317-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":164,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1007\/s12031-025-02317-8","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"34"}}